Ozempic 1.34 mg/mL
semaglutide · INJECTION, SOLUTION · Novo Nordisk Pharmaceutical Industries, LP
No Recall HistoryCurrently in Shortage
Plain English
Ozempic is a injection, solution containing semaglutide at 1.34 mg/mL, taken subcutaneous. Manufactured by Novo Nordisk Pharmaceutical Industries, LP.
Key Facts
- Brand Name
- Ozempic
- Generic Name
- semaglutide
- NDC Code (Product)
0169-4130- Manufacturer
- Novo Nordisk Pharmaceutical Industries, LP
- Strength
- 1.34 mg/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA209637
- Drug Class
- GLP-1 Receptor Agonist [EPC]
- Marketing Start
- 09/30/2020
Recall History
No Recall HistoryFrequently Asked Questions
What is Ozempic used for?
Ozempic contains semaglutide. It is a injection, solution taken subcutaneous. Consult your doctor for specific uses.
Is Ozempic a controlled substance?
Ozempic is not classified as a controlled substance by the DEA.
What is the generic name for Ozempic?
The generic name for Ozempic is semaglutide. There are 8 other brand versions of semaglutide.
What is the NDC code for Ozempic 1.34 mg/mL?
The NDC (National Drug Code) for Ozempic 1.34 mg/mL is 0169-4130, listed by Novo Nordisk Pharmaceutical Industries, LP.